Skip to main content
Article
Phase II study of dasatinib in the treatment of head and neck squamous cell carcinoma (HNSCC)
Journal of Clinical Oncology (2009)
  • H. D. Brooks, University of Texas MD Anderson Cancer Center
  • B. Glisson, University of Texas MD Anderson Cancer Center
  • C. Lu, University of Texas MD Anderson Cancer Center
  • A. Sabichi, University of Texas MD Anderson Cancer Center
  • F. Johnson, University of Texas MD Anderson Cancer Center
  • L. Ginsberg, University of Texas MD Anderson Cancer Center
  • B. Bekele, University of Texas MD Anderson Cancer Center
  • V. Papadimitrakopoulou, University of Texas MD Anderson Cancer Center
Publication Date
May 20, 2009
DOI
10.1200/JCO.2009.27.15_SUPPL.6022
Citation Information
H. D. Brooks, B. Glisson, C. Lu, A. Sabichi, et al.. "Phase II study of dasatinib in the treatment of head and neck squamous cell carcinoma (HNSCC)" Journal of Clinical Oncology Vol. 27 (2009) p. 6022 - 6022
Available at: http://works.bepress.com/heather-brooks2/8/